RMG Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
RMG Wealth Management's EW Position: Q3 2026 in Review
RMG Wealth Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 300 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #218.
RMG Wealth Management first reported a position in EW in Q2 2025 and has held it in 5 quarters since. The position peaked at $27.9K in Q2 2026. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- RMG Wealth Management held 300 shares of Edwards Lifesciences worth $26.8K as of Q3 2026.
- RMG Wealth Management left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up ﹤0.01% of RMG Wealth Management's portfolio in Q3 2026, its #218 holding.
- RMG Wealth Management first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
- RMG Wealth Management's Edwards Lifesciences position peaked at $27.9K in Q2 2026.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on RMG Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.